ZLB Logo (USPTO, 10/29/2001)
USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark ZLB was filed as Word and figurative mark on 10/29/2001 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".
| Trademark form | Word and figurative mark |
| File reference | 76331795 |
| Application date | October 29, 2001 |
| Publication date | December 9, 2003 |
Trademark owner
10 WANKDORFSTRASSE
3000 BERN 22
CH
3000 BERN 22
CH
Trademark representatives
goods and services
1
CHEMICAL REAGENTS FOR INDUSTRIAL, SCIENTIFIC AND MEDICAL RESEARCH USE; SERA FOR SCIENTIFIC, INDUSTRIAL AND MEDICAL RESEARCH, NAMELY, THE PRODUCTION OF PHARMACEUTICALS, VACCINES, MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS; SERA ALTERNATIVES IN THE NATURE OF BIOCHEMICALS, NAMELY, PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES FOR USE IN CELL CULTURE SCIENTIFIC RESEARCH; BIOLOGICALS, NAMELY PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES DERIVED FROM BACTERIA VIRUSES AND ANIMALS, FOR USE AS DILUENTS IN CELL CULTURE SCIENTIFIC RESEARCH APPLICATIONS; SERA PRODUCTS IN THE NATURE OF BIOLOGICALS, NAMELY, PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES, DERIVED FROM BACTERIAL VIRUSES AND ANIMALS, FOR USE AS DILUENTS IN CELL CULTURE SCIENTIFIC RESEARCH APPLICATIONS; DIAGNOSTIC CHEMICAL AND BIOLOGICAL REAGENTS FOR SCIENTIFIC, INDUSTRIAL OR MEDICAL RESEARCH USE; BIOCHEMICALS, NAMELY, MONOCLONAL ANTIBODIES USED FOR IN VITRO SCIENTIFIC OR RESEARCH USE; CELL CULTURE MEDIA FOR SCIENTIFIC, LABORATORY OR MEDICAL RESEARCH, NAMELY, CELL MEDIA FOR USE IN THE PRODUCTION OF PHARMACEUTICALS, VACCINES, MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS
5
DIAGNOSTIC REAGENTS FOR IN VITRO USE IN BIOCHEMISTRY, CLINICAL CHEMISTRY AND MICROBIOLOGY; MEDIA FOR BACTERIOLOGICAL CULTURES, NAMELY, CHEMICALLY DEFINED MEDIA SUPPLEMENTS FOR THE GROWTH OF BACTERIA, VIRAL OR ANIMAL CELLS IN CULTURE; PHARMACEUTICAL PREPARATIONS DERIVED FROM PLASMA AND RECOMBINANT DNA TECHNOLOGY FOR THE PREVENTION AND/OR TREATMENT OF BLOOD DISORDERS; BLOOD PRODUCTS, NAMELY, PLASMA VOLUME EXPANDERS, HUMAN ALBUMIN, BLOOD CLOTTING FACTORS AND IMMUNOGLOBULINS FOR MEDICAL AND CLINICAL USE; TEST KITS CONSISTING PRIMARILY OF CLINICAL DIAGNOSTIC REAGENTS AND BLOOD PLASMA; MEDIA FOR BACTERIOLOGICAL CULTURES FOR MEDICAL PURPOSES
10
DEVICES AND INSTRUMENTS FOR THE ADMINISTRATION AND DELIVERY OF PHARMACEUTICAL PREPARATIONS FOR USE IN THE HUMAN IMMUNE DISORDERS AND HUMAN IMMUNE SYSTEM
40
FRACTIONATION OF PLASMA TO OBTAIN INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF DIFFERENT PHARMACEUTICAL PRODUCTS; TREATMENT OF HUMAN BIOLOGICAL PRODUCTS, NAMELY, CUSTOM MANUFACTURING AND FRACTIONATION OF BLOOD AND PLASMA
42
HEALTH AND HYGIENE CARE, NAMELY, HEALTHCARE SERVICES; SCIENTIFIC AND INDUSTRIAL RESEARCH
ID: 1376331795